Ultrasound-guided microwave ablation for secondary hyperparathyroidism: a systematic review and meta-analysis

References

• Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. CJASN. 2015;10(1):98–109.
   PubMed Web of Science ®Google Scholar
• Drueke TB. Cell biology of parathyroid gland hyperplasia in chronic renal failure. J Am Soc Nephrol. 2000;11(6):1141–1152.
   PubMed Web of Science ®Google Scholar
• Hargrove GM, Pasieka JL, Hanley DA, et al. Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease. Am J Nephrol. 1999;19(5):559–564.
   PubMed Web of Science ®Google Scholar
• Saunders RN, Karoo R, Metcalfe MS, et al. Four gland parathyroidectomy without reimplantation in patients with chronic renal failure. Postgrad Med J. 2005;81(954):255–258.
   PubMed Web of Science ®Google Scholar
• Goldsmith D, Kothawala P, Chalian A, et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD. Am J Kidney Dis. 2009;53(6):1002–1013.
   PubMed Web of Science ®Google Scholar
• Floege J, Kim J, Ireland E, et al.; on behalf of the ARO Investigators. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26(6):1948–1955.
   PubMed Web of Science ®Google Scholar
• Akizawa T, Akiba T, Hirakata H, et al. Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial. 2015;19(3):225–234.
   PubMed Web of Science ®Google Scholar
• Komaba H, Moriwaki K, Goto S, et al. Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan. Am J Kidney Dis. 2012;60(2):262–271.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Li M, You L, et al. Effects and safety of calcimimetics in end stage renal disease patients with secondary hyperparathyroidism: a meta-analysis. PloS One. 2012;7(10):e48070.
   PubMed Web of Science ®Google Scholar
• Raggi P, ADVANCE Study Group, Chertow GM, Torres PU, Csiky B, Naso A, Nossuli K, et al. The advance study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. 2011;26(4):1327–1339.
   PubMed Web of Science ®Google Scholar
• Torres PU, Prie D, Beck L, et al. New therapies for uremic secondary hyperparathyroidism. J Ren Nutr. 2006;16(2):87–99.
   PubMed Web of Science ®Google Scholar
• Xu SY, Wang Y, Xie Q, et al. Percutaneous sonography-guided radiofrequency ablation in the management of parathyroid adenoma. Singapore Med J. 2013;54(7):e137–e140.
   PubMed Web of Science ®Google Scholar
• Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol. 2014;24(9):2052–2058.
   PubMed Web of Science ®Google Scholar
• Zhuo L, Peng LL, Zhang YM, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease-a pilot study. Radiol. 2017;282(2):576–584.
   PubMed Web of Science ®Google Scholar
• Liu F, Yu X, Liu Z, et al. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism. Int J Hyperth. 2019;36(1):835–840.
   PubMed Web of Science ®Google Scholar
• Moher D, PRISMA Group, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269. w64.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• Miller JJ. The inverse of the Freeman–Tukey double arcsine transformation. Am Statist. 1978;32(4):138.
   Web of Science ®Google Scholar
• Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Statist. 1950;21(4):607–611.
   Google Scholar
• Borenstein M, Hedges L, Higgins J, et al. Part 4: Heterogeneity. Introduction to Meta-Analysis Chichester. West Sussex, England: John Wiley & Sons, Ltd.; 2009, p. 105–211. Retrieved from https://chb.bmn.ir/Asset/files/Introduction-to-Meta-Analysis.pdf
   Google Scholar
• Sutton AJ, Abrams KR, Jones DR, et al. Methods for Meta-analysis in medical research. Vol 22. Chichester: Wiley; 2000, p. 3112–3114. Retrieved from https://onlinelibrary.wiley.com/doi/abs/https://doi.org/10.1002/sim.1565
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443–3457.
   PubMed Web of Science ®Google Scholar
• Luo L, Guan B, Jiang X, et al. Ultrasound-guided percutaneous microwave ablation for the treatment of secondary hyperparathyroidism. Chin J Nephrol. 2015;31(12):940.
   Google Scholar
• Diao Z, Liu X, Qian L, et al. Efficacy and its predictor in microwave ablation for severe secondary hyperparathyroidism in patients undergoing haemodialysis. Int J Hyperth: Off J Eur Soc Hyperth Oncol, NAHG. 2016;32(6):614–622.
   PubMed Web of Science ®Google Scholar
• Gao Z, Xiao L, Feng J, et al. Ultrasound-guided microwave thermal ablation for the treatment of severe secondary hyperparathyroidism in maintenance hemodialysis. CJITWN. 2016;17(12):1072–1073.
   Google Scholar
• Yu MA, Yao L, Zhang L, et al. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperth. 2016;32(2):180–186.
   PubMed Web of Science ®Google Scholar
• Zhao J, Qian L, Zu Y, et al. Efficacy of ablation therapy for secondary hyperparathyroidism by ultrasound guided percutaneous thermoablation. Ultrasound Med Biol. 2016;42(5):1058–1065.
   PubMed Web of Science ®Google Scholar
• Diao Z, Wang L, Li D, et al. Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis. Ren Fail. 2017;39(1):140–145.
   PubMed Web of Science ®Google Scholar
• Ding X, Chen Y, Wu Y, et al. Comparison of efficacy between microwave ablation and parathyroidectomy for secondary hyperparathyroidism. J Minim Invasive Med. 2017;12(3):334–337.
   Google Scholar
• Liao Q, Liu J, Huang J, et al. The efficiency of ultrasound guided microwave ablation therapy for secondary hyperparathyroidism. Chin J Blood Purif. 2017;16(11):741–745.
   Google Scholar
• Liu J. The effect of microwave ablation on secondary hyperparathyroidism. JCM. 2017;15(4):57–58.
   Google Scholar
• Jiang B, Wang X, Yao Z, et al. Microwave ablation vs. parathyroidectomy for secondary hyperparathyroidism in maintenance hemodialysis patients. Hemodial Int Symp Home Hemodial. 2019;23(2):247–253.
   PubMed Web of Science ®Google Scholar
• Li X, An C, Yu M, et al. US-guided microwave ablation for secondary hyperparathyroidism in patients after renal transplantation: a pilot study. Int J Hyperth. 2019;36(1):322–327.
   PubMed Web of Science ®Google Scholar
• Zhuo L, Zhang L, Peng L, et al. Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection. Int J Hyperth. 2019;36(1):29–35.
   PubMed Web of Science ®Google Scholar
• Cao X, Huo S, Peng L, et al. Clinical efficacy of microwave ablation in treatment of secondary hyperparathyroidism ineligible for surgical resection. Chin J Interv Imaging Ther. 2020;17(3):145–148.
   Google Scholar
• Ma H, Ouyang C, Huang Y, et al. Comparison of microwave ablation treatments in patients with renal secondary and primary hyperparathyroidism. Ren Fail. 2020;42(1):66–76.
   PubMed Web of Science ®Google Scholar
• Xiao R, Zhao Z, Wei Y, et al. Safety and efficacy of modified liquid isolation method in microwave ablation in treatment of secondary hyperparathyroidism. Chin J Interv Imaging Ther. 2020;17(3):137–140.
   Google Scholar
• Fang J, Zhao W, Li Q, et al. Ultrasound-guided microwave ablation for secondary hyperparathyroidism: the analysis of short-term efficacy. Chinese J Ultrasound Med. 2020;36(5):476–479.
   Google Scholar
• Kong X, Zhao Y, Li X. Efficacy and value of ultrasound-guided percutaneous microwave alblation therapy for secondary hyperparathyroidism. J Med Imaging. 2020;30(7):1161–1165.
   Google Scholar
• Pan C, Zhou X, Du P, et al. Efficacy of ultrasonography guided percutaneous microwave ablation for secondary hyperparathyroidism in patients with chronic renal failure. Chin J Clin. 2020;48(8):928–931.
   Google Scholar
• Song J. The study of clinical effects of microwave ablation in the treatment of secondary hyperparathyroidism. Master's Thesis. 2020;1(1):1–43.
   Google Scholar
• Wei Y, Yu MA, Qian LX, et al. Hypocalcemia after ultrasound-guided microwave ablation and total parathyroidectomy for secondary hyperparathyroidism: a retrospective study. Int J Hyperth. 2020;37(1):819–825.
   PubMed Web of Science ®Google Scholar
• Diao Z, Qian L, Teng C, et al. Microwave ablation versus parathyroidectomy for severe secondary hyperparathyroidism in patients on hemodialysis: a retrospective multicenter study. Int J Hyperth. 2021;38(1):213–219.
   PubMed Web of Science ®Google Scholar
• Li D, Wang G, Chen X, et al. Long-Term effect of microwave ablation on patients undergoing hemodialysis for moderate secondary hyperparathyroidism: a retrospective cohort study. J Ultrasound Med: Off J Am Ins Ultrasound Med. 2021. DOI:https://doi.org/10.1002/jum.15638
   Google Scholar
• Wang K, Gao Z, Liu S, et al. Long-term outcomes of microwave ablation for secondary hyperparathyroidism in maintenance hemodialysis patients. Ther Apheresis and Dial: Off Peer-Rev J Int Soc Apheresis, Japanese Soc for Apheresis, Japanese Soc for Dial Ther. 2021. DOI:https://doi.org/10.1111/1744-9987.13640
   Google Scholar
• Li X, Wei Y, Shao H, et al. Efficacy and safety of microwave ablation for ectopic secondary hyperparathyroidism: a feasibility study. Int J Hyperth. 2019;36(1):647–653.
   PubMed Web of Science ®Google Scholar
• Yu M, Cao X, Peng L, et al. Ultrasound-guided microwave ablation of secondary hyperparathyroidism after renal transplantation. Chin J Interv Imaging Ther. 2020;17(3):133–136.
   Google Scholar
• KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1–S130.
   Google Scholar
• Cao XJ, Zhao ZL, Wei Y, et al. Efficacy and safety of microwave ablation treatment for secondary hyperparathyroidism: systematic review and meta-analysis. Int J Hyperth. 2020;37(1):316–323.
   PubMed Web of Science ®Google Scholar
• Chen H, Lin C, Wu C, et al. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg. 2011;253(4):786–790.
   PubMed Web of Science ®Google Scholar
• Ospina NS, Thompson GB, Lee RA, et al. Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1. J Clin Endocrinol & Metab. 2015;100(1).
   Web of Science ®Google Scholar
• Andrioli M, Riganti F, Pacella CM, et al. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: present and future perspectives. AJR Am J Roentgenol. 2012;199(5):1164–1168.
   PubMed Web of Science ®Google Scholar
• Kovatcheva R, Vlahov J, Stoinov J, et al. High-intensity focussed ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism. Nephrol Dial Transplant. 2012;27(1):76–80.
   PubMed Web of Science ®Google Scholar
• Nawrot I, Chudziński W, Ciąćka T, et al. Reoperations for persistent or recurrent primary hyperparathyroidism: results of a retrospective cohort study at a tertiary referral center. Med Sci Monit. 2014;20:1604–1612.
   PubMed Web of Science ®Google Scholar
• Yue W, Chen L, Wang S, et al. Locoregional control of recurrent papillary thyroid carcinoma by ultrasound-guided percutaneous microwave ablation: a prospective study. Int J Hyperth. 2015;31(4):403–408.
   PubMed Web of Science ®Google Scholar